Lung function measurement in general practice: a comparison of the Escort spirometer with the Micromed turbine spirometer and the mini-Wright peak flow meter  by Jones, K.P. & Mullee, M.A.
Respiratory Medicine (1995) 89, 657-663 
Original Articles 
Lung function measurement in general practice: a 
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Micromed turbine spirometer and the mini-Wright 
peak flow meter 
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*Primary Medical Care Group, Faculty of Medicine and TMedical Statistics and Computing, University of 
Southampton, Southampton, U.K. 
It is important that new types of spirometer for widespread clinical use are pragmatically evaluated in primary 
care. This study compared measurements taken by a new portable Fleisch pneumotachograph spirometer 
(known as the Escort) with those of the commonly used mini-Wright peak flow meter and the Micromed 
Pocket turbine spirometer. A pragmatic study was conducted in two phases during routine surgeries at 
Aldermoor Health Centre, Southampton. Phase 1 compared the new spirometer with the mini-Wright peak 
flow meter and Phase 2 compared the new spirometer and the turbine spirometer. One hundred patients aged 
5-88 years (56 patients with a history of chronic respiratory complaints and 44 patients without) entered Phase 
1, and 100 patients aged 6-82 years (62 patients with a history of chronic respiratory complaints and 38 
patients without) entered Phase 2. Each patient contributed only once to each phase, but some entered both 
phases on separate occasions. Ninety-five percent limits of agreement (mean f 2 SD) were wide for all 
comparisons. Graphical plots revealed trends towards higher Escort values as mean values rose compared 
with both mini-Wright and turbine readings for peak expiratory flow rate and forced expiratory volume in one 
second. Possible over-reading of peak expiratory flow rate with the mini-Wright meter at low mean values was 
also seen. Readings taken with these different types of meter cannot be interchanged with confidence in clinical 
practice. The clinical significance of the theoretically more accurate measures of lung function produced with 
the new meter, and indeed of spirometry itself, needs further investigation. 
Introduction 
After a long campaign conducted by a number of 
different agencies, the placing of mini peak flow 
meters onto the Drug Tariff in the U.K. in September 
1990 was heralded as a major advance in the man- 
agement of asthma within general practice. Since 
there is evidence that up to 90% of patients with 
asthma are managed entirely within this sector of 
health care (1,2), it could thus be hoped that major 
alterations in morbidity might follow and the rise in 
prescribing expenditure incurred by the provision of 
meters in primary care easily justifiable. Indeed, 
self-management plans based on home peak flow 
monitoring have been shown to be beneficial in a 
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small uncontrolled study in a hospital outpatient 
department (3), and at least as useful as a symptom- 
based plan in general practice (4). However, more 
recent evidence has not confirmed these benefits (5). 
Peak flow measurement has become commonplace 
in general practice whereas the use of spirometry, 
much used in hospital-based chest medicine, is much 
more sporadic and not well standardized. Compari- 
sons of peak flow measured on different types of 
instruments have demonstrated that readings cannot 
be directly equated (61 l), making the whole issue of 
the role of spirometers in general practice problem- 
atic. Some evidence suggests that the additional 
measurement of forced expiratory volume in 1 s 
(FEV,) makes little difference to therapeutic decision- 
making in a primary care based asthma clinic (12). 
The specified required accuracy of peak flow 
meters placed on the Drug Tariff is f 10% of the 
value generated on the original dial-type Wright 
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meter (13) but American standards for spirometry 
(which do not mention peak flows) insist on & 5% of 
true laboratory values (14). Subsequent American 
guidance on peak flow meters require & 10% accu- 
racy and 5 5% reproducibility (15). Recent evidence 
comparing a whole range of spirometers and peak 
flow meters against laboratory-generated known peak 
flow rates has shown major discrepancies will all pre- 
scribable meters in their adult versions and in most of 
the low range versions (16). In particular, the mini- 
Wright peak flow meter, which is likely to be the most 
commonly used instrument in general practice, was 
shown to over-read at lower true values and under- 
read at high values. The same effect was demon- 
strated, though less severely, with the dial-type Wright 
on which British standards are currently based. Only 
peak flow measurements derived from a pneumo- 
tachograph fulfilled the American criteria for accu- 
racy across the whole range of likely peak flow values. 
The clinical effectiveness of using mini peak flow 
meters, especially at home where good technique and 
compliance may be questionable (17,18) has thus 
been called into question and alternative methods of 
ascertaining accurate peak flow records need to be 
considered. A new, hand-held, portable spirometer 
known as the Escort which incorporates a Fleisch 
pneumotachograph is now being marketed by Vita- 
lograph at a cost of around f500. This instrument is 
not only more likely to be accurate on theoretical 
grounds, but also can be easily calibrated in clinical 
practice and can be adjusted for temperature. It has 
been tested against a wedge-bellows spirometer and a 
dial-type Wright in a hospital setting and found to 
yield comparable results (19). 
Therefore, the Escort spirometer has an acceptable 
performance both in the hospital and the laboratory. 
However, since so much asthma care takes place in 
general practice, where use of spirometers is likely to 
be sporadic and non-standardized, it is important to 
compare peak flow recordings in clinical use of the 
new meter with those of the mini-Wright peak flow 
meter, as the most commonly used prescribable peak 
flow meter, and other measures with the Micromed 
Pocket turbine spirometer, as the most commonly 
used type of spirometer in primary care (20), in order 
to assess the pragmatic use and usefulness of the new 
device in that setting. 
Methods 
The study was conducted in two phases between 
July and October 1992 at the urban shared-list gen- 
eral practice of approximately 8400 patients incor- 
porated within our academic department. In the first 
phase, the best of three peak flow rate recordings 
using forced vital capacity (FVC) manoeuvres on one 
Escort spirometer was compared with the best of 
three peak flow rate recordings using peak flow 
manoeuvres on one previously unused mini-Wright 
peak flow meter. The type of expiration employed has 
been shown not to make a significant difference to 
recorded values (9). In the second phase, the better of 
two FVC manoeuvres on the Escort spirometer was 
compared with the better of two similar manoeuvres 
on a single turbine spirometer. In addition to peak 
expiratory flow rates, comparisons in this phase were 
also made of measurements of FEV, and FVC. The 
difference in numbers of manoeuvres is explained by 
the need to avoid undue fatigue in some subjects, 
some of whom had severe airflow obstruction. 
All patients aged 5 years and over with a past or 
present clinical history of asthma or chronic obstruc- 
tive airways disease, and an approximate one in three 
other attendees at the routine surgeries of KJ were 
invited to undergo lung function testing in order to 
evaluate the new spirometer. All subjects were 
coached in the proper use of the lung function 
equipment by KJ and their measurements were 
recorded under his supervision. The order of use of 
the instruments being tested was randomized. 
Repeatability was assessed using a subset of 28 of the 
subjects in the first phase and using all of the subjects 
in the second phase according to the methods of 
Bland and Altman (21). 
The new spirometer was calibrated at the start of 
each surgery session using a standard 1 1 syringe and 
corrected for temperature in the consulting room. 
The accuracy of the turbine spirometer (which can- 
not be calibrated in routine use) was also tested at the 
start of each session. Neither instrument was more 
than 5% out at any time. 
Data were entered on an IBM-compatible personal 
computer using Data Entry and analysed using the 
SPSS-PC+ (version 4.0) software package (22). 
Graphical comparisons between the two instruments 
were made using Harvard Graphics (23) according to 
the methods of Bland and Altman (21). 
Results 
Forty-eight males and 52 females, with a mean age 
of 36.7 years (SD 21.2 years, range 5-88 years), 
completed Phase 1 and 56 males and 44 females, with 
a mean age of 41.6 years (SD 20.8 years, range 6-82 
years), completed Phase 2. There was no significant 
difference between the two phases in terms of either 
age (t=1.64, d.f.=198, P=O.lO) or gender k*=1.28, 
d.f.=2, P=O.26). There were 56 subjects with a 
history of chronic respiratory complaints and 44 
patients without in Phase 1; the corresponding figures 
for Phase 2 were 62 and 38, respectively. 
The mean differences between the instruments 
(Escort-mini-Wright/turbine), together with the 95% 
limits of agreement (plus or minus twice the SD of the 
differences) and the coefficients of repeatability (twice 
the SD of the repeatability data) are shown in Table 1. 
Figure 1 shows the ‘line of equality’ plots for each of 
these four comparisons and Fig. 2 shows the ‘Bland 
and Altman’ difference vs. mean plots for each com- 
parison. The 95% limits of agreement are seen to be 
wide for ahcomparisons, but not significantly greater 
than the coefficients of repeatability. With the com- 
parison between the peak expiratory flow readings on 
the Escort and the mini-Wright peak flow meter, 
there is an apparent tendency for the mini-Wright to 
exceed the Escort at values below 400 1 min - ’ and an 
increasing trend for the opposite to be seen above 
SOOlmin-‘. However, this relative bias is only 
marked at high values. With the comparison between 
the Escort and turbine spirometers, the bias in FEV, 
seems to increase with mean value but remains fairly 
small. The differences in FVC are negligible. The 
differences between the two spirometers for peak 
expiratory flow are more substantial, but appear to 
be consistent and thus could be adjusted for. 
No trend is seen in the comparisons of FVC 
in Phase 2, but there is a trend towards higher 
Escort readings for both FEV, and peak expiratory 
flow rate as mean values rise. No significant effects 
were noted when order of use or temperature were 
examined. 
Discussion 
As with previous comparisons of different types of 
spirometer and peak flow meters (611,24,25), it is 
clear from our data that values gleaned from one type 
of machine cannot be compared with confidence with 
those from another. However, almost all the lack of 
agreement is due to lack of repeatability, a problem 
with all lung function measurements whatever the 
instrument, probably due to shortcomings in the 
users of the devices rather than to the devices them- 
selves. Before Miller et al. (16) produced their data 
questioning the accuracy of portable peak flow 
meters (including the turbine spirometer), this would 
have led us to repeat our comment at the end of a 
previous exercise comparing the turbine and the 
mini-Wright (9) that ‘the mini-Wright is likely to 
remain the preferred instrument in general practice’. 
General practitioners currently make frequent use 
of peak flow readings both indirectly, in nurse-run 
asthma clinics and in home diaries often for self- 
management (2,26), and directly in routine consul- 
tations. Different types of peak flow meter may be 
used on separate occasions and, even with different 
samples of the same type of meter, reproducibility of 
results is far from guaranteed. This use of peak flow 
readings is likely to result in therapeutic decisions 
which could be rendered questionable by the inac- 
curacies of the instruments on which they rely. For 
instance, a patient with a mini-Wright best ever peak 
flow rate of 600 1 min- ’ might produce a mini- 
Wright reading of 380 1 mini ’ during an attack, 
when their true reading was only 300 1 min ~ ‘. An 
inappropriate decision to withhold oral steroids 
could result from the higher erroneous figure. It is 
possible, therefore, that better and thus safer man- 
agement could arise from the use of more reliable 
equipment. 
The new Escort spirometer is portable, easily 
charged, and very easy to use with patients of all ages 
above 4 years. Its facility for automatically recording 
the best values from a series was certainly convenient 
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Table I Results of instrument comparisons 
Instrument 
compared Measurements Mean 
with Escort compared difference 
Standard 
deviation 
95% limits 
of agreement 
Coefficient of 
repeatability 
Mini-Wright PEFR 
Turbine PEFR 
Turbine FEV, 
Turbine FVC 
-8lmin-’ 
66lmin~’ 
0.21 1 
0.04 1 
58lmin-’ 
45lmin~’ 
0.19 I 
0.33 1 
- 108%+124lmin~’ 
-24+156lmin-’ 
- 0.17-+0.59 1 
- 0.62-+0.70 1 
Escort: 95 1 min ‘; 
Mini-Wright: 89 1 min - ’ 
Escort: 113 1 min - ‘; 
Turbine: 66 1 min - 1 
Escort: 0.46 1; 
Turbine: 0.37 1 
Escort: 0.69 1; 
Turbine: 0.48 1 
PEFR, peak expiratory flow rate; FEV,, forced expiratory volume in 1 s; FVC, forced vital capacity. 
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1 2 3 4 5 6 7 0 1 2 3 4 5 6 
Turbine spirometer (1) Turbine spirometer (1) 
200 400 600 800 
Turbine spirometer (1 min-‘) 
0 200 400 600 800 i 
Escort spirometer (1 min-i) 
Fig. I Line of equality plots for: (a) forced vital capacity, Micromed turbine spirometer VS. Escort spirometer; (b) forced 
expiratory volume in 1 s, turbine VS. Escort; (c) peak expiratory flow rate, turbine VS. Escort; (d) peak expiratory flow rate, 
Escort VS. mini-Wright peak flow meter. 
for the clinician. Moreover, its use of the pneumo- 
tachograph makes it likely to be acceptably accurate 
[i.e. within American standards (15)], which the cur- 
rent mini meters and turbine appear not to be (16). 
The under-reading of the turbine at high flows shown 
by both Miller et al. (16) and suggested by our own 
data could be due to the inertia of the turbine 
vane and/or to high resistance to tlow through the 
turbine swirl vanes. The Escort has no moving 
parts, samples pressures 100 times sP i and is well 
within American recommendations for back pres- 
sure. It does, however, need frequent re-calibration 
and adjustment for temperature. The theoretical 
advantages of the Escort are not clinically evident 
from our data since this instrument had higher 
coefficients of repeatability than both the other 
meters. 
Which lung function parameters and which 
machine(s) are best for general practice? Firstly, what 
is the case for spirometry? As well as the recent 
questioning of the accuracy of mini peak flow meters, 
there are theoretical reasons why the measurement of 
FEV, is better at reflecting changes in small airway 
function than peak expiratory flow estimation (28). 
Measurement of FVC and the ratio of FEV’IFVC 
may also allow other diseases as well as asthma to 
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be diagnosed. Ratios showing normal, obstructive, 
restrictive, or mixed patterns may help in referral 
decisions. 
American guidelines for the diagnosis and manage- 
ment of asthma state that ‘all patients suspected 
of having asthma should have office spirometry 
performed, at minimum, for initial assessment. Most 
physicians’ offices can successfully use an office 
spirometer . .’ (28). In addition, significant research 
from the Netherlands concerning declining lung 
function in patients with asthma and chronic ob- 
structive lung disease on differing therapeutic regimes 
might not have shown such clear results without the 
recording of these spirometric variables (29). 
Secondly, what is the case for peak flow measure- 
ment alone? The American guidelines reflect a long- 
standing U.S. preference for the measurement of 
FEV, which is not echoed so strongly in the U.K. 
The latest U.K. asthma management guidelines 
make no mention of spirometry rather than peak 
flow measurement even in the section on areas of 
uncertainty (30). 
In practical use, Dekker et al. have found changes 
in peak expiratory flow to be sufficiently accurate for 
predicting changes in FEV, (31). Peak flow meters 
are widely available by prescription to patients and 
thus their clinicians in U.K. primary care, but access 
to formal spirometry in general practice is sporadic 
and not centrally resourced. There is clearly room for 
further evaluation and discussion in this area. One 
aspect of this debate must be to examine the rel- 
evance of other spirometric variables in primary care. 
Some evidence suggests that general practitioners are 
making measurements of such variables, but their 
indications are not sufficiently well defined (20) and 
their relevance for therapeutic decision-making in 
doubt (12). 
There is thus a doubt about the accuracy of the 
commonly used mini peak flow meters (16), but also 
some debate concerning when and whether formal 
spirometry should be performed in the care of 
patients with respiratory complaints. Resolving the 
issue of the usefulness of spirometry vs. simple peak 
flow measurement in general practice needs to be part 
of the standard setting in asthma care requested by 
the U.K. government in its White Paper ‘The Health 
of the Nation’ (32), since the resource implications 
are considerable. The inaccuracies of mini peak flow 
meters could be fairly easily rectified by re-calibration 
and re-scaling, but this would necessitate the exten- 
sive exercise of providing new scales for or replacing 
many hundreds of thousands of meters. This process 
is being delayed by lack of worldwide agreement on 
scale standards (33). The cost-effectiveness and 
proper role of spirometers and spirometry in primary 
care should be delineated while agreement is being 
sought. The acceptability of doctors, nurses and 
patients of a range of devices for measuring lung 
function in general practice also needs to be investi- 
gated so that an informed choice of equipment can be 
made. 
In conclusion, the Escort spirometer is a welcome 
addition to the range of portable instruments avail- 
able for potential use in primary care, but does not 
appear to offer larger clinical benefits over other 
devices. Consistency of device, likely to be provided 
in prescribable peak flow meters, remains more 
important. 
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